Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)
| 42.11 BATS BZX Real-Time Price As of 10:59am ET |  +0.12 / +0.29%Today’s Change | 31.52 Today|||52-Week Range 54.98 | -9.11% Year-to-Date |
Latest RARE News | Press Releases
No recent news for Ultragenyx Pharmaceutical Inc.
Today’s Trading
| Previous close | 41.99 |
| Today’s open | 42.04 |
| Day’s range | 41.61 - 42.20 |
| Volume | 5,861 |
| Average volume (3 months) | 852,063 |
| Market cap | $3.3B |
Data as of 10:59am ET, 12/06/2023
Growth & Valuation
| Earnings growth (last year) | -51.09% |
| Earnings growth (this year) | +19.31% |
| Earnings growth (next 5 years) | +86.06% |
| Revenue growth (last year) | +3.39% |
| P/E ratio | NM |
| Price/Sales | 8.92 |
| Price/Book | 7.98 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EVOEvotec SE | +0.26 | +2.65% |
| ---- | ||
| FOLDAmicus Therapeutics ... | -0.12 | -1.03% |
| ACADACADIA Pharmaceutica... | -0.37 | -1.66% |
Data as of 10:59am ET, 12/06/2023
Financials
| Next reporting date | February 20, 2024 |
| EPS forecast (this quarter) | -$1.86 |
| Annual revenue (last year) | $363.3M |
| Annual profit (last year) | -$707.4M |
| Net profit margin | -194.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Novato, California |
Forecasts
